How Dermatology Research Gaps Represent Untapped Markets for Pharmaceutical Companies

2019-07-15T11:12:17+00:00By |Tags: |

Gaps in dermatological research present potentially lucrative market opportunities for pharmaceutical companies. Patients that suffer from skin conditions and diseases also benefit. Effective treatments relieve irritating, chronic, and often painful symptoms, which improves their quality of life and lifts the psychological and social burden of a visible dermatological issue.

How to Launch a Successful, Cost-Effective Neurodevelopmental Study

2019-09-03T15:26:14+00:00By |Tags: , , |

How to run a more efficient pediatric clinical trial: Although pediatric trials overall cost roughly the same as adult clinical trials according to one analysis, they generally produce a more modest return on investment. To ensure your neurodevelopmental or other pediatric study completes in a cost-effective, efficient manner, follow these tips:

Rare Disease Spotlight: C3 Glomerulopathy

2019-09-03T16:51:05+00:00By |Tags: |

C3 glomerulopathy (C3G), a rare kidney disease, affects only two or three people out of every one million. That’s only a couple people out of the entire population of San Jose, California or Austin, Texas. Although C3G only affects a select few, without treatment it can lead to severe kidney damage and failure, necessitating expensive dialysis or transplant. To date, there is no specific, effective therapy. As a CRO that understands the challenges involved in researching rare disease treatments, we’re here to help drug developers deliver the most effective clinical trials possible—on time and on budget. Speak with one of our rare disease experts today to find out how we can help you develop your next rare disease program.

Prepare for Success: How Advance Planning Keeps Clinical Trials on Track

2019-10-31T14:41:50+00:00By |Tags: , , |

Why Do So Many Clinical Trials Fall Behind? Clinical trials are not immune to missed deadlines and cost overruns. However, with proper advance planning, you can up the odds of success and avoid major glitches. Our studies show that about 33% of all clinical trials are behind schedule at any given moment. These trials under-perform due to operational failures; meaning, they’re behind schedule, over budget, or the data produced lacks the quality needed to support an approval.

Download our Precision Medicine Checklist

Complete the form below to receive a link to download this checklist
close-link

Schedule a call with one of our experts today

Let us know how we can help. Complete the form below and we will schedule a call
close-link

Start your FREE Trial Rescue Assessment!

Complete the form below and we will provide our free trial rescue assessment.
close-link

Download our Patient-Centric Trials White Paper

Complete the form below to receive a link to download this white paper
close-link

Download our Data Science White Paper

Complete the form below to receive a link to download this white paper
close-link

Schedule a TALOS™ Control Center Demo

Complete the form below to schedule a demo with our program development team
close-link

Download our Rare Disease Checklist

Complete the form below to receive a link to download this checklist
close-link

Download our Dermatology White Paper

Complete the form below to receive a link to download this white paper
close-link

Get Access to "Making Most of Trial Data" Webinar

Complete the form below to receive a link to access this webinar
close-link

Download our Precision Oncology White Paper

Complete the form below to receive a link to download this whitepaper
close-link

Download our Rare Disease White Paper

Complete the form below to receive a link to download this whitepaper
close-link

Get access to "Strategies for Successful Digital Therapeutics Clinical Trials" Webinar

Complete the form below to receive a link to access this on-demand webinar
close-link